Concepedia

Azhar Toma

AT

Statistics

Publications

10

Citations

484

H-Index

10

Active since

2016

Affiliations

GlaxoSmithKline (Belgium)(Current)

Manna Research

Universities at Shady Grove

GlaxoSmithKline (United States)

The University of Sydney

Azhar Toma is an author at GlaxoSmithKline (Belgium) specializing in vaccination, vaccinology, and immunization.

Publications per year

2016–2022

10

Publications

10

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 101 citations · Full text

, , +17

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 93 citations · Full text

, , +17

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Joanne M. Langley, Naresh Aggarwal, Azhar Toma et al. · The Journal of Infectious Diseases · 2016 · 65 citations · Full text

, , +17

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois et al. · Vaccine · 2019 · 65 citations · Full text

, , +17

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

Timo Vesikari, Adam Finn, Pierre Van Damme et al. · JAMA Network Open · 2021 · 61 citations · Full text

, , +17

1–5 of 10